28-Mar-2024
No headlines found.
Danaher Schedules First Quarter 2024 Earnings Conference Call
PRNewswire (Thu, 21-Mar 4:15 PM ET)
Danaher to Present at TD Cowen Health Care Conference
PRNewswire (Tue, 27-Feb 4:15 PM ET)
Globe Newswire (Sun, 25-Feb 9:00 PM ET)
Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets
PRNewswire (Thu, 22-Feb 4:15 PM ET)
Danaher Announces Quarterly Dividend
PRNewswire (Wed, 21-Feb 4:15 PM ET)
PRNewswire (Mon, 5-Feb 7:30 AM ET)
Danaher Reports Fourth Quarter and Full Year 2023 Results
PRNewswire (Tue, 30-Jan 6:00 AM ET)
PRNewswire (Tue, 9-Jan 7:30 AM ET)
Danaher CEO to Comment on Financial Performance
PRNewswire (Mon, 8-Jan 4:15 PM ET)
Danaher to Present at J.P. Morgan Healthcare Conference
PRNewswire (Tue, 2-Jan 5:00 PM ET)
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in two segments--life sciences and diagnostics--after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
Danaher trades on the NYSE stock market under the symbol DHR.
As of March 28, 2024, DHR stock price climbed to $249.72 with 2,113,810 million shares trading.
DHR has a beta of 1.17, meaning it tends to be more sensitive to market movements. DHR has a correlation of 0.34 to the broad based SPY ETF.
DHR has a market cap of $184.72 billion. This is considered a Large Cap stock.
Last quarter Danaher reported $6 billion in Revenue and $2.09 earnings per share. This beat revenue expectation by $317 million and exceeded earnings estimates by $.20.
In the last 3 years, DHR stock traded as high as $333.96 and as low as $182.09.
The top ETF exchange traded funds that DHR belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.
DHR has underperformed the market in the last year with a price return of +24.0% while the SPY ETF gained +33.6%. DHR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +7.6% and -2.1%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
DHR support price is $246.12 and resistance is $251.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DHR stock will trade within this expected range on the day.